The effect of remnant size on the outcome of subtotal thyroidectomy for thyrotoxicosis

Michie, W.; Duncan, Thomas; Hems, G; Crooks, J.

doi:10.1002/bjs.1800590715

Cited by 33 publications

(13 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Before operation 33 (17%) of 191 patients had a positive tanned red cell All patients were operated on in the same surgical unit and a standard pattem of procedure and assessment was used. Remnant Weight.-As reported elsewhere (Hedley et al, 1971) estimates of remnuant weight in individual patients show considerable variation; the standard deviations of the estimates were as high as 25% of the true weight in a cadaver study.…”

Section: Resultsmentioning

confidence: 56%

Prediction of Hypothyroidism after Partial Thyroidectomy for Thyrotoxicosis

Michie¹,

Pegg²,

Bewsher³

1972

BMJ

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 56%

Prediction of Hypothyroidism after Partial Thyroidectomy for Thyrotoxicosis

Michie¹,

Pegg²,

Bewsher³

1972

BMJ

View full text Add to dashboard Cite

“…Haque GHMS is a common though acceptable complication of subtotal and total thyroidectomy and is readily treated with thyroxin 12 . As in Bangladesh prevalence of thyroid disease is high and the scope of thyroid surgery is increasing day by day, the study was conducted with the aim to find out the rate of complications of thyroid surgery and to see the different modalities of thyroid surgery performed for thyroid swelling.…”

Section: Incidence Of Complications Of Thyroid Surgerymentioning

confidence: 99%

Incidence of Complications of Thyroid Surgery

Haque

Farid²,

Islam

2017

Med. Today

View full text Add to dashboard Cite

show abstract

“…Bereits in den 70er Jahren konnte gezeigt werden, dab zwischen der Gr6Be der operativ belassenen Restschilddrfise und der Rate postoperativer Hyperthyreosen bzw. Hypothyreosen eine direkte Korrelation besteht [10,25,35].…”

Section: Surgical Treatment Of Graves' Diseaseunclassified

Operatives Therapiekonzept der Immunthyreopathie

Dralle

Schober

Hesch

1987

Langenbecks Arch Chiv

View full text Add to dashboard Cite

73 patients with Graves' disease, surgically treated from 1975-1986, were investigated retrospectively. 43 patients, treated by subtotal thyroidectomy (Enderlen-Hotz) and a bilateral thyroid remnant of a total of about 8-12 g, were compared with 30 patients, treated by a modified subtotal thyroidectomy leaving a unilateral thyroid remnant of about 4-8 g, with respect to preoperative duration of disease, indications for surgical treatment, weight of resected specimens, operative complications and postoperative thyroid function. Surgical complications were similar in both groups. After subtotal thyroidectomy 14/43 patients (33%) displayed either recurrent hyperthyroidism (9/43, 21%) or local recurrence of Graves' goiter (3/43, 7%) or both (2/43, 5%). The modified subtotal resected group showed no recurrences of the disease. After subtotal thyroidectomy 11 patients were euthyroid without thyroid medication (26%) compared to only two patients (7%) after the modified procedure of subtotal thyroid resection. To prevent recurrences of goiter as well as hyperthyroidism and, on the other hand, to achieve euthyroid function postoperatively without need for thyroid replacement therapy, subtotal thyroidectomy with a small thyroid remnant of about 4-8 g is recommended for all patients with large goiter and a chronic recurrent course of the disease or with iodine induced thyrotoxicosis. Patients with non-recurrent Graves' disease but large goiter probably benefit from subtotal thyroidectomy with a larger thyroid remnant of about 8-12 g.

show abstract

The effect of remnant size on the outcome of subtotal thyroidectomy for thyrotoxicosis

Cited by 33 publications

References 19 publications

Prediction of Hypothyroidism after Partial Thyroidectomy for Thyrotoxicosis

Prediction of Hypothyroidism after Partial Thyroidectomy for Thyrotoxicosis

Incidence of Complications of Thyroid Surgery

Operatives Therapiekonzept der Immunthyreopathie

Contact Info

Product

Resources

About